Actinic Keratoses: Evidence-Based Treatment Options
126891268912689
Dr. Hanke, a dermatologic surgeon who needs no introduction (but I’ll give one anyway!) provided us with an evidence-based discussion of field treatments available for actinic keratoses at ODAC 2021 conference.
Just to name a few of Dr. Hanke’s accomplishments, he is the current Senior Vice President of the Skin Cancer Foundation, Senior editor of JDD, and the former president of the AAD, A …
Dr. Hanke, a dermatologic surgeon who needs no introduction (but I’ll give one anyway!) provided us with an evidence-based discussion of field treatments available for actinic keratoses at ODAC 2021 conference.
Just to name a few of Dr. Hanke’s accomplishments, he is the current Senior Vice President of the Skin Cancer Foundation, Senior editor of JDD, and the former president of the AAD, A … Continue reading "Actinic Keratoses: Evidence-Based Treatment Options"
Actinic keratoses represent the most common dermatologic diagnosis in patients older than 45 years old in the United States and account for 5.2 million visits annually.1 Cutaneous field cancerization represents areas with a high burden of both clinical and subclinical actinic damage. Cryotherapy can often be combined with topical chemotherapy for a synergistic approach. We continue our series, The … 